Expert Outlook: Sarepta Therapeutics Through The Eyes Of 25 Analysts
Expert Outlook: Sarepta Therapeutics Through The Eyes Of 25 Analysts
专家展望：sarepta therapeutics在25位分析师的眼中
Ratings for Sarepta Therapeutics (NASDAQ:SRPT) were provided by 25 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
在过去三个月中，25位分析师对Sarepta Therapeutics (NASDAQ:SRPT)的评级提供了看好和看淡的观点。
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
下表提供了他们最近的评级快照，展示了情绪在过去30天中的演变情况，并将其与之前的月份进行比较。
In the assessment of 12-month price targets, analysts unveil insights for Sarepta Therapeutics, presenting an average target of $182.8, a high estimate of $235.00, and a low estimate of $128.00. Marking an increase of 10.38%, the current average surpasses the previous average price target of $165.61.
在对12个月的股价目标进行评估时，分析师们揭示了Sarepta Therapeutics的一些见解，提出了一个平均目标价$182.8，一个高估价$235.00和一个低估价$128.00。目前的平均价比以前的平均价$165.61高了10.38%。
Decoding Analyst Ratings: A Detailed Look
分析师评级解读：详细解析
The standing of Sarepta...
通过对最...
登录免费看全文
登录/注册